Cite
HARVARD Citation
Vale, C. et al. (n.d.). Addition of docetaxel or bisphosphonates to standard of care in men with localised or metastatic, hormone-sensitive prostate cancer: a systematic review and meta-analyses of aggregate data. Lancet oncology. 17 (2), pp. 243-256. [Online].